A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

This study has been completed.
Information provided by National Institutes of Health Clinical Center (CC)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001383

Locations


United States, Maryland
	National Cancer Institute (NCI)
	Bethesda, Maryland, United States, 20892

Sponsors and Collaborators

National Cancer Institute (NCI)